感染指南

订阅

MedSci主页 / 所有栏目 / 感染指南

2020 ACIP建议：流感季节流感疫苗防控

2020-08-21 免疫实践咨询委员会 MMWR Recomm Rep . 2020 Aug 21;69(8):1-24.

流感流感疫苗

本文是对2019-20ACIP关于流感季节流感疫苗防控建议的更新，对于年龄≥6个月的无接种禁忌的额人群，均建议每年常规接种流感疫苗。本文主要内容包括流感疫苗接种建议，流感疫苗成份和可用产品等。

中文标题：

2020 ACIP建议：流感季节流感疫苗防控

英文标题：

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2020-21 Influenza Season

发布机构：

免疫实践咨询委员会

发布日期：

2020-08-21

简要介绍：

本文是对2019-20ACIP关于流感季节流感疫苗防控建议的更新，对于年龄≥6个月的无接种禁忌的额人群，均建议每年常规接种流感疫苗。本文主要内容包括流感疫苗接种建议，流感疫苗成份和可用产品等。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020-21 ACIP建议：流感季节流感疫苗防控.pdf)] GetToolGuiderByIdResponse(projectId=1, id=8ef381c00195910f, title=2020 ACIP建议：流感季节流感疫苗防控, enTitle=Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2020-21 Influenza Season, guiderFrom=MMWR Recomm Rep . 2020 Aug 21;69(8):1-24., authorId=0, author=, summary=本文是对2019-20ACIP关于流感季节流感疫苗防控建议的更新，对于年龄&ge;6个月的无接种禁忌的额人群，均建议每年常规接种流感疫苗。本文主要内容包括流感疫苗接种建议，流感疫苗成份和可用产品等。, cover=https://img.medsci.cn/2020830/1598722112284_2020535.jpg, journalId=0, articlesId=null, associationId=469, associationName=免疫实践咨询委员会, associationIntro=Immunization Action Coalition下分支，服务于疾病控制和预防中心（CDC），制定免疫计划及推荐疫苗使用建议。, copyright=0, guiderPublishedTime=Fri Aug 21 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>本文是对2019-20ACIP关于流感季节流感疫苗防控建议的更新，对于年龄&ge;6个月的无接种禁忌的额人群，均建议每年常规接种流感疫苗。本文主要内容包括流感疫苗接种建议，流感疫苗成份和可用产品等。</p> </div> </div> </div>, tagList=[TagDto(tagId=1249, tagName=流感), TagDto(tagId=3812, tagName=流感疫苗)], categoryList=[CategoryDto(categoryId=9, categoryName=感染, tenant=100), CategoryDto(categoryId=35, categoryName=预防医学, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=3812, guiderKeyword=流感疫苗, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3180, appHits=77, showAppHits=0, pcHits=593, showPcHits=3103, likes=0, shares=7, comments=18, approvalStatus=1, publishedTime=Sun Aug 30 01:28:54 CST 2020, publishedTimeString=2020-08-21, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sun Aug 30 01:28:45 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 12:20:53 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020-21 ACIP建议：流感季节流感疫苗防控.pdf)])
2020-21 ACIP建议：流感季节流感疫苗防控.pdf
下载请点击：
评论区 (12)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=922859, encodeId=c22c922859df, content=需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Thu Feb 04 19:54:22 CST 2021, time=2021-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888094, encodeId=72f988809489, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5f785172962, createdName=146de694m00暂无昵称, createdTime=Thu Sep 24 22:56:01 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884498, encodeId=00e2884498fe, content=积分兑换还是很不方便！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fa42358987, createdName=qian005, createdTime=Fri Sep 11 10:17:23 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881109, encodeId=bcef881109a1, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42705312246, createdName=1488d5e7m58暂无昵称, createdTime=Mon Aug 31 05:30:36 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881028, encodeId=cd6a88102852, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200830/c5d4eaa7f91746ae91939d37dac1b9ac/20e45e8069924d3295d5cfa3c464fa92.jpg, createdBy=06ce5329129, createdName=zZ大壮哥, createdTime=Sun Aug 30 19:50:00 CST 2020, time=2020-08-30, status=1, ipAttribution=)]
    2021-02-04 神盾医疗局局长Jack

    需要

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=922859, encodeId=c22c922859df, content=需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Thu Feb 04 19:54:22 CST 2021, time=2021-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888094, encodeId=72f988809489, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5f785172962, createdName=146de694m00暂无昵称, createdTime=Thu Sep 24 22:56:01 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884498, encodeId=00e2884498fe, content=积分兑换还是很不方便！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fa42358987, createdName=qian005, createdTime=Fri Sep 11 10:17:23 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881109, encodeId=bcef881109a1, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42705312246, createdName=1488d5e7m58暂无昵称, createdTime=Mon Aug 31 05:30:36 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881028, encodeId=cd6a88102852, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200830/c5d4eaa7f91746ae91939d37dac1b9ac/20e45e8069924d3295d5cfa3c464fa92.jpg, createdBy=06ce5329129, createdName=zZ大壮哥, createdTime=Sun Aug 30 19:50:00 CST 2020, time=2020-08-30, status=1, ipAttribution=)]
    2020-09-24 146de694m00暂无昵称

    好好学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=922859, encodeId=c22c922859df, content=需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Thu Feb 04 19:54:22 CST 2021, time=2021-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888094, encodeId=72f988809489, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5f785172962, createdName=146de694m00暂无昵称, createdTime=Thu Sep 24 22:56:01 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884498, encodeId=00e2884498fe, content=积分兑换还是很不方便！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fa42358987, createdName=qian005, createdTime=Fri Sep 11 10:17:23 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881109, encodeId=bcef881109a1, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42705312246, createdName=1488d5e7m58暂无昵称, createdTime=Mon Aug 31 05:30:36 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881028, encodeId=cd6a88102852, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200830/c5d4eaa7f91746ae91939d37dac1b9ac/20e45e8069924d3295d5cfa3c464fa92.jpg, createdBy=06ce5329129, createdName=zZ大壮哥, createdTime=Sun Aug 30 19:50:00 CST 2020, time=2020-08-30, status=1, ipAttribution=)]
    2020-09-11 qian005

    积分兑换还是很不方便！

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=922859, encodeId=c22c922859df, content=需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Thu Feb 04 19:54:22 CST 2021, time=2021-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888094, encodeId=72f988809489, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5f785172962, createdName=146de694m00暂无昵称, createdTime=Thu Sep 24 22:56:01 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884498, encodeId=00e2884498fe, content=积分兑换还是很不方便！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fa42358987, createdName=qian005, createdTime=Fri Sep 11 10:17:23 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881109, encodeId=bcef881109a1, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42705312246, createdName=1488d5e7m58暂无昵称, createdTime=Mon Aug 31 05:30:36 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881028, encodeId=cd6a88102852, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200830/c5d4eaa7f91746ae91939d37dac1b9ac/20e45e8069924d3295d5cfa3c464fa92.jpg, createdBy=06ce5329129, createdName=zZ大壮哥, createdTime=Sun Aug 30 19:50:00 CST 2020, time=2020-08-30, status=1, ipAttribution=)]
    2020-08-31 1488d5e7m58暂无昵称

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=922859, encodeId=c22c922859df, content=需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Thu Feb 04 19:54:22 CST 2021, time=2021-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888094, encodeId=72f988809489, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5f785172962, createdName=146de694m00暂无昵称, createdTime=Thu Sep 24 22:56:01 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884498, encodeId=00e2884498fe, content=积分兑换还是很不方便！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fa42358987, createdName=qian005, createdTime=Fri Sep 11 10:17:23 CST 2020, time=2020-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881109, encodeId=bcef881109a1, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42705312246, createdName=1488d5e7m58暂无昵称, createdTime=Mon Aug 31 05:30:36 CST 2020, time=2020-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881028, encodeId=cd6a88102852, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200830/c5d4eaa7f91746ae91939d37dac1b9ac/20e45e8069924d3295d5cfa3c464fa92.jpg, createdBy=06ce5329129, createdName=zZ大壮哥, createdTime=Sun Aug 30 19:50:00 CST 2020, time=2020-08-30, status=1, ipAttribution=)]
    2020-08-30 zZ大壮哥

    学习

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

预防和或治疗流感药物临床研究指导原则

国家药品监督管理局药品审评中心（CDE） · 2019-10-31

2018 ACOG委员会意见：妊娠女性疑似或确认流感的评估和治疗（No.753）

美国妇产科医师学会(ACOG,American College of Obstetricians and Gynecologists) · 2018-09-24

老年人流感和肺炎链球菌疫苗接种中国专家建议

中华医学会老年医学分会 · 2018-02-20

2016-2017 AAP儿童流感的预防与控制建议

美国儿科学会(AAP,American Academy of Pediatrics) · 2016-09-06

儿童流感诊断与治疗专家共识(2015年版)

中华医学会儿科学分会呼吸学组 · 2016-04-27

拓展阅读

2017-18 ACIP建议：流感季节流感疫苗防控

免疫实践咨询委员会(ACIP,Advisory Committee on Immunization Practices) · 2017-11-01

2018-2019 AAP儿童流感的预防与控制建议

美国儿科学会(AAP,American Academy of Pediatrics) · 2018-09-03

《儿童流感的预防与控制建议（2018-2019年）》解读

暂未更新 · 2019-02-20

2019-20 ACIP建议：流感季节流感疫苗防控

免疫实践咨询委员会(ACIP,Advisory Committee on Immunization Practices) · 2019-08-23

2019 意大利建议：成人自身免疫性风湿病患者流感和肺炎球菌疫苗接种

国外风湿免疫科相关专家小组 · 2019-08-27

中国流感疫苗预防接种技术指南（2020-2021）

中国疾病预防控制中心(CDC,Chinese Center For Disease Control And Prevention) · 2020-09-10